Products that appear promising in early clinical trials of somatic-cell or gene therapy will usually enter a commercial development process with two important parallel components.
Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the